Lumbar neurolytic sympathetic blockades provide immediate and long-lasting improvement of painless walking distance and muscle metabolism in patients with severe peripheral vascular disease

Martin Gleim^*, Christoph Maier, Uwe Melchert

^*Corresponding author for this work